Phospho-Trin 250 Neutral Interactions
There are 71 drugs known to interact with Phospho-Trin 250 Neutral (potassium phosphate/sodium phosphate), along with 9 disease interactions. Of the total drug interactions, 28 are major, 28 are moderate, and 15 are minor.
- View all 71 medications that may interact with Phospho-Trin 250 Neutral
- View Phospho-Trin 250 Neutral disease interactions (9)
Most frequently checked interactions
View interaction reports for Phospho-Trin 250 Neutral (potassium phosphate / sodium phosphate) and the medicines listed below.
- Aceta (acetaminophen)
- acetaminophen
- acetaminophen / hydrocodone
- albuterol
- All Day Allergy (cetirizine)
- alpha-lipoic acid
- Aspir 81 (aspirin)
- aspirin / caffeine
- atorvastatin
- belatacept
- carvedilol
- cranberry
- Farxiga (dapagliflozin)
- furosemide
- gabapentin
- glucosamine
- Humalog KwikPen (insulin lispro)
- irbesartan
- magnesium oxide
- multivitamin
- Myfortic (mycophenolic acid)
- Nasacort (triamcinolone nasal)
- pantoprazole
- polyethylene glycol 3350
- Pristiq (desvenlafaxine)
- psyllium
- tamsulosin
- Tresiba (insulin degludec)
- Tums Extra Strength 750 (calcium carbonate)
- Vitamin D3 (cholecalciferol)
Phospho-Trin 250 Neutral disease interactions
There are 9 disease interactions with Phospho-Trin 250 Neutral (potassium phosphate / sodium phosphate) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- hypocalcemia
- phosphate imbalance
- electrolyte imbalance
- aluminum toxicity/renal impairment
- cardiac disease
- hypomagnesemia
Report options
QR code containing a link to this page
More about Phospho-Trin 250 Neutral (potassium phosphate / sodium phosphate)
- Phospho-Trin 250 Neutral consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
